RxDoctor Payments Data

Timothy Damron, MD

Orthopaedic Surgery · East Syracuse, NYNPI 1699770602

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (48.7%), education and food and beverage — rather than concentrated in one kind of arrangement. 6 manufacturers reported payments, led by Bone Support Inc. at 48.7% of the total. Reporting peaked in 2019 at $1,000 and has fallen 73.4% since, to $266 in 2025. That places this record below the midpoint for orthopaedic surgery clinicians in NY, where the typical reported total is $4,024.

$2,154in general payments, 2019–2025

Across 12 payments — averaging $179.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bone Support Inc.$1K
  • Prodigy Surgical Distribution, Inc.$522
  • Stryker$443
  • Linkbio Corp$97
  • International Rehabilitative Sciences, Inc$28
  • SK Life Science, Inc.$13
$10,412in research payments, 2019–2025

Across 6 payments — averaging $1735.33 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Bone Support Inc.$4K
  • BONE Support AB$4K
  • Stryker$2K

What the payments were for

  • Consulting fees$1,05049%
  • Travel & lodging$20510%
  • Food & beverage$37617%
  • Education$52224%

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,154 in reported general payments places this provider in the 35th percentile of 1,079 orthopaedic surgery providers in New York.

See all orthopaedic surgery providers in New York →

Medicare billing

Part B allowed, 2024
$342,299
Medicare patients
607
Services billed
16,448

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cephalexin19$209
Oxycodone Hcl50$185

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in East Syracuse

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →